Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

T cell vaccines against Mycobacterium tuberculosis (Mtb) and other pathogens are based on the principle that memory T cells rapidly generate effector responses upon challenge, leading to pathogen clearance. Despite eliciting a robust memory CD8+ T cell response to the immunodominant Mtb antigen TB10.4 (EsxH), we find the increased frequency of TB10.4-specific CD8+ T cells conferred by vaccination to be short-lived after Mtb challenge. To compare memory and naïve CD8+ T cell function during their response to Mtb, we track their expansions using TB10.4-specific retrogenic CD8+ T cells. We find that the primary (naïve) response outnumbers the secondary (memory) response during Mtb challenge, an effect moderated by increased TCR affinity. To determine whether the expansion of polyclonal memory T cells is restrained following Mtb challenge, we used TCRβ deep sequencing to track TB10.4-specific CD8+ T cells after vaccination and subsequent challenge in intact mice. Successful memory T cells, defined by their clonal expansion after Mtb challenge, express similar CDR3β sequences suggesting TCR selection by antigen. Thus, both TCR-dependent and -independent factors affect the fitness of memory CD8+ responses. The impaired expansion of the majority of memory T cell clonotypes may explain why some TB vaccines have not provided better protection.

More information Original publication

DOI

10.1371/journal.ppat.1005380

Type

Journal article

Publication Date

2016-01-01T00:00:00+00:00

Volume

12

Addresses

D, e, p, a, r, t, m, e, n, t, , o, f, , M, i, c, r, o, b, i, o, l, o, g, y, , a, n, d, , P, h, y, s, i, o, l, o, g, i, c, a, l, , S, y, s, t, e, m, s, ,, , U, n, i, v, e, r, s, i, t, y, , o, f, , M, a, s, s, a, c, h, u, s, e, t, t, s, , M, e, d, i, c, a, l, , S, c, h, o, o, l, ,, , W, o, r, c, e, s, t, e, r, ,, , M, a, s, s, a, c, h, u, s, e, t, t, s, ,, , U, n, i, t, e, d, , S, t, a, t, e, s, , o, f, , A, m, e, r, i, c, a, .

Keywords

CD8-Positive T-Lymphocytes, Animals, Mice, Inbred C57BL, Mice, Transgenic, Mice, Knockout, Mice, Tuberculosis, Disease Models, Animal, Receptors, Antigen, T-Cell, Tuberculosis Vaccines, Enzyme-Linked Immunosorbent Assay, Adoptive Transfer, Flow Cytometry, Cell Separation, Lymphocyte Activation, Immunologic Memory, High-Throughput Nucleotide Sequencing